--- title: "PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial" ocid: "ocds-h6vhtk-06faf0" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06faf0" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06faf0.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06faf0.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "University of Glasgow" published: "2026-09-16" --- # PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial Buyer: University of Glasgow Current stage: Tender OCID: ocds-h6vhtk-06faf0 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06faf0) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06faf0.json) ## Summary The University of Glasgow is procuring a contract for the manufacture of investigational medicinal products for a clinical trial. The requirement includes final Qualified Person release, storage and distribution to study sites, with an optional integrated interactive response technology (IRT) system providing forecasting capabilities. This is a pharmaceutical goods opportunity, suited to manufacturers and specialist clinical-trial supply providers able to manage controlled product release, storage and distribution. The buyer is the University of Glasgow, based in Glasgow. Delivery is associated with the study sites for the clinical trial. The contract also includes electronic ordering, payment and invoicing arrangements, and requires suppliers to propose community benefits such as employment and training, workforce development, equality and diversity initiatives, supply-chain opportunities, and educational or work-experience activity. The procurement has reached tender: the buyer invited offers through a selective competitive procedure with negotiation. It is a two-stage process with successive reduction, and three candidates were to be invited to the second stage; the buyer reserved the right to award on initial bids without further negotiation. Tenders had to be submitted electronically in English by 19 October 2026 at 12:00. The estimated contract period is 900 days, comprising an initial 18-month term with an optional extension of up to 12 months. The evaluation gives 18% to IMP manufacture, 52% to IMP-related questions and 30% to price. The optional IRT service is assessed for information only. Variants are not allowed. This opportunity suits pharmaceutical manufacturers and clinical-trial supply specialists with demonstrable capability in investigational medicinal product production, Qualified Person release, storage and distribution to multiple study sites. Suppliers should be able to support the relevant clinical-trial supply chain and may also offer an integrated IRT system with forecasting capabilities. Financial and organisational capacity requirements are substantial: bidders need at least two years of accounts showing annual turnover of £450,000. Required insurance includes product liability of £2 million, public liability of £5 million, employer’s liability of £5 million and professional indemnity of £1 million. The successful supplier must also commit to community benefits, potentially creating subcontracting and supply-chain opportunities for SMEs, third-sector organisations and supported businesses. ## Notice PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities. This procurement process is being conducted using the Competitive Procedure with Negotiation (CPN) in accordance with the requirements of Regulation 30 of the PC(S)R 2015. Although this procurement is being conducted under the Competitive Procedure with Negotiation (CPN), it is structured differently from a typical CPN process. This approach has been adopted to enhance the efficiency of evaluating supplier responses across both stages (SPD and ITT). Tender documents available from Public Contracts Scotland. Tender returns should be submitted via Public Contracts Scotland, no paper copies will be accepted. Should paper tenders be submitted, they will be rejected. Further to this any questions or communications regarding individual tender exercises must be sent via the Public Contracts Scotland Portal. Tender queries received through any other channel will not be answered. Should users of Public Contracts Scotland have any problems with the web site they should contact website Support Desk, contact details can be found by following the 'Contact Us' option on the left hand menu at http://www.publiccontractsscotland.gov.uk/default.aspx ### Lot Information Lot 1 PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical Trial, (Including Final Qualified Person Release, Storage and Distribution to Study Sites) and Option to Provide an Integrated IRT System with Forecasting Capabilities for the period of 18 months with the option to extend for a further period of up to 12 months. For detailed specification, please refer to PURCH3013 - Schedule 1A - Invitation to Tender Renewal: Initial term is 18 months with optional extension of 12 months ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/087673-2026 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Selective | | Procurement method details | Competitive procedure with negotiation | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 16 Sep 2026 | | Submission deadline | 19 Oct 2026 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | University of Glasgow | | Locality | GLASGOW | | Postcode area | Glasgow | | Postcode | G12 8QQ | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM3 West Central Scotland | | ITL 3 | TLM32 Glasgow City | | Local authority | Glasgow City | | Electoral ward | Hillhead | | Westminster constituency | Glasgow North | | Delivery location | TLM82 Glasgow City | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33000000 - Medical equipments, pharmaceuticals and personal care products - 33600000 - Pharmaceutical products ## Release History - 16 Sep 2026 at 11:28 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/087673-2026 ## Notice URLs - http://www.gla.ac.uk/ - http://www.publiccontractsscotland.gov.uk/ - http://www.publiccontractsscotland.gov.uk/default.aspx - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000843130 - https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ - https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=843130 - https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00108 - https://www.publiccontractsscotland.gov.uk/sitehelp/help_guides.aspx ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06faf0. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06faf0.json.